secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001779128-24-000123
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Air Mobility Q3 revenue $74.9M (+4.8%); net loss $(2.0)M; Adj EBITDA $4.2M
--------------------------------------------------------------------------------

- Revenue $74.9M, up 4.8% YoY; gross margin improved 520 bps to 19.3%.
- Net loss $(2.0)M vs income $0.3M YoY; Adjusted EBITDA $4.2M, improvement of $3.4M.
- Operating cash flow $6.4M, up $4.3M; free cash flow before aircraft acquisitions $3.7M, up $2.4M.
- Medical segment Adj EBITDA improved 15.1%; Passenger segment Adj EBITDA up $2.8M, achieving trailing 12-month profitability.
- Reaffirmed guidance: positive Adjusted EBITDA in 2024 and double-digit millions in 2025; announced strategic alliance with OrganOx.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912824000123/0001779128-24-000123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912824000123/blde-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001779128-24-000123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer